Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
10,341,285
-
Share change
-
+7,180,169
-
Total reported value
-
$246,622,000
-
Price per share
-
$23.89
-
Number of holders
-
21
-
Value change
-
+$171,435,669
-
Number of buys
-
18
Institutional Holders of Silence Therapeutics plc - ADS (SLN) as of Q4 2021
As of 31 Dec 2021,
Silence Therapeutics plc - ADS (SLN) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,341,285 shares.
The largest 10 holders included
Lombard Odier Asset Management (USA) Corp, Deep Track Capital, LP, FRAZIER MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Consonance Capital Management LP, BVF INC/IL, AXA S.A., ADAGE CAPITAL PARTNERS GP, L.L.C., GREAT POINT PARTNERS LLC, and CANTOR FITZGERALD, L. P..
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.